Filing Details
- Accession Number:
- 0000885590-12-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-08 14:17:40
- Reporting Period:
- 2012-11-06
- Filing Date:
- 2012-11-08
- Accepted Time:
- 2012-11-08 14:17:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1477123 | Mitchell Lloyd Segal | 4787 Levy Street Montreal A8 H4R 2P9 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2012-11-06 | 745 | $54.44 | 17,609 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This number represents the weighted average purchase price for all purchases of common stock purchased by the reporting officer.
- This number represents common shares purchased and other equity awards that were previously reported in Table 1.